CHIPOR, HORSE, and beyond: unraveling the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer. [PDF]
Lim MC.
europepmc +1 more source
Preoperative nutritional risk assessment in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for colorectal carcinomatosis [PDF]
Nathan Banaste+6 more
openalex +1 more source
Hyperthermic intraperitoneal chemotherapy (HIPEC) increases risk of local anesthetic systemic toxicity (LAST). [PDF]
Tsuchiya M, Takesada H, Mizutani K.
europepmc +1 more source
Recurrence and Survival Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Small Bowel Adenocarcinoma [PDF]
Akshat Saxena+3 more
openalex +1 more source
Perfusate Flow Rate: An Overlooked Factor in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)? [PDF]
Theile D, Czock D.
europepmc +1 more source
Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Colorectal Carcinomatosis: If at First You Don't Succeed... [PDF]
Laura A. Lambert, Paul F. Mansfield
core +1 more source
Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy - Can We Do Better? [PDF]
Alberto V ME+5 more
europepmc +1 more source
Prognostic value of diffusion-weighted imaging to cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for patients with gastric cancer and peritoneal metastases. [PDF]
Xin X+11 more
europepmc +1 more source